Home
/
VACCINEX, INC.
/
Financials
/
Quarterly
VACCINEX, INC. — Quarterly Financials
Quarterly figures from SEC EDGAR XBRL filings (10-Q)
These figures are extracted from XBRL-tagged quarterly reports (10-Q) that VACCINEX, INC. filed with the SEC. Values are as reported for each individual quarter (Q1, Q2, Q3, Q4) — not cumulative year-to-date. Negative figures indicate a loss.
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2024
Sep 30, 2024
$52.0K
Nov 14, 2024
Q2
2024
Jun 30, 2024
$232.0K
Aug 14, 2024
Q1
2024
Mar 31, 2024
$104.0K
May 15, 2024
Q3
2024
Sep 30, 2023
$20.0K
Nov 14, 2024
Q2
2024
Jun 30, 2023
$550.0K
Aug 14, 2024
Q1
2024
Mar 31, 2023
$550.0K
May 15, 2024
Q3
2023
Sep 30, 2022
$50.0K
Nov 13, 2023
Q3
2022
Sep 30, 2021
$50.0K
Nov 14, 2022
Q2
2022
Jun 30, 2021
$850.0K
Aug 15, 2022
Q1
2022
Mar 31, 2021
$850.0K
May 16, 2022
Q3
2021
Sep 30, 2020
$625.0K
Nov 8, 2021
Q3
2020
Sep 30, 2019
$404.0K
Nov 13, 2020
Q2
2020
Jun 30, 2019
$25.0K
Aug 14, 2020
Q1
2020
Mar 31, 2019
$94.0K
May 14, 2020
Q3
2019
Sep 30, 2018
$198.0K
Nov 12, 2019
Q2
2019
Jun 30, 2018
$126.0K
Aug 14, 2019
Q1
2019
Mar 31, 2018
$206.0K
May 15, 2019
Net Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2024
Sep 30, 2024
($5.73M)
Nov 14, 2024
Q2
2024
Jun 30, 2024
($5.63M)
Aug 14, 2024
Q1
2024
Mar 31, 2024
($3.90M)
May 15, 2024
Q3
2024
Sep 30, 2023
($4.91M)
Nov 14, 2024
Q2
2024
Jun 30, 2023
($7.06M)
Aug 14, 2024
Q1
2024
Mar 31, 2023
($4.96M)
May 15, 2024
Q3
2023
Sep 30, 2022
($4.76M)
Nov 13, 2023
Q2
2023
Jun 30, 2022
($5.38M)
Aug 14, 2023
Q1
2022
Mar 31, 2022
($4.60M)
May 16, 2022
Q3
2022
Sep 30, 2021
($5.21M)
Nov 14, 2022
Q2
2022
Jun 30, 2021
($5.97M)
Aug 15, 2022
Q1
2022
Mar 31, 2021
($6.57M)
May 16, 2022
Q3
2021
Sep 30, 2020
($8.75M)
Nov 8, 2021
Q2
2021
Jun 30, 2020
($6.50M)
Aug 16, 2021
Q1
2021
Mar 31, 2020
($7.15M)
May 17, 2021
Q3
2020
Sep 30, 2019
($7.64M)
Nov 13, 2020
Q2
2020
Jun 30, 2019
($8.83M)
Aug 14, 2020
Q1
2020
Mar 31, 2019
($9.07M)
May 14, 2020
Q3
2019
Sep 30, 2018
($6.60M)
Nov 12, 2019
Q2
2019
Jun 30, 2018
($6.61M)
Aug 14, 2019
Operating Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2024
Sep 30, 2024
($4.55M)
Nov 14, 2024
Q2
2024
Jun 30, 2024
($5.72M)
Aug 14, 2024
Q1
2024
Mar 31, 2024
($5.07M)
May 15, 2024
Q3
2024
Sep 30, 2023
($5.83M)
Nov 14, 2024
Q2
2024
Jun 30, 2023
($7.08M)
Aug 14, 2024
Q1
2024
Mar 31, 2023
($4.99M)
May 15, 2024
Q3
2023
Sep 30, 2022
($4.79M)
Nov 13, 2023
Q2
2023
Jun 30, 2022
($5.40M)
Aug 14, 2023
Q1
2023
Mar 31, 2022
($4.59M)
May 15, 2023
Q3
2022
Sep 30, 2021
($5.06M)
Nov 14, 2022
Q2
2022
Jun 30, 2021
($5.67M)
Aug 15, 2022
Q1
2022
Mar 31, 2021
($6.24M)
May 16, 2022
Q3
2021
Sep 30, 2020
($8.58M)
Nov 8, 2021
Q2
2021
Jun 30, 2020
($6.50M)
Aug 16, 2021
Q1
2021
Mar 31, 2020
($7.16M)
May 17, 2021
Q3
2020
Sep 30, 2019
($7.68M)
Nov 13, 2020
Q2
2020
Jun 30, 2019
($8.86M)
Aug 14, 2020
Q1
2020
Mar 31, 2019
($9.14M)
May 14, 2020
Q3
2019
Sep 30, 2018
($6.45M)
Nov 12, 2019
Q2
2019
Jun 30, 2018
($6.56M)
Aug 14, 2019